Another potentially responsive cohort could be individuals with rare diseases related to non-lethal variation in genes involved in programmed axon degeneration, such as those experiencing NMNAT2-related polyneuropathy (Huppke et al., 2019), because this activates the pathway very specifically in a way that can be fully rescued in mice (Gilley et al., 2017). Here, NMNAT2 is linked to polyneuropathy.